Merck & Co. Inc. (MRK) Opens in Green Amid FDA Rejection Related to Diabetes Drugs
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S.
Posts Tagged ‘NYSE:MRK’
10 Biggest Recent Accounting Scandals in America
The 10 biggest recent accounting scandals in America have shaken the nation and affected investor confidence.
10 Least Obese Countries in the World
The 10 least obese countries in the world are mostly from Asia and Africa.
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc.
Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis drug it owns.
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years.
The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA.
The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co., Inc. (MRK)
The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK).
Pharmaceutical Executives From Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ) Met Trump
United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher cost manufacturing at the...
Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes.
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Bristol-Myers Squibb Co (BMY) To Share In Sales Of Merck & Co., Inc. (MRK) Keytruda Following Litigation Settlement
Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd.
Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
Palantir Technologies Inc and Merck & Co., Inc.
11 Fattest Countries in The World
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Millennium Management Makes Billion-Dollar Investments in These 2 Consumer Stocks, Plus Big Moves in Merck, CMS, More
Millennium Management is a global investment management firm that was founded in 1989.
Merck & Co., Inc. (MRK) Gets Coveted Approval For Keytruda
Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK).
Five Dow Jones Stocks That Can Outperform The Market
The Dow Jones Industrial Average (DJIA) comprises of 30 companies representing a diverse collection of stocks from all market sectors.
Is Merck & Co., Inc. (MRK) A Good Stock To Buy?
At Insider Monkey, we track over 700 of the most successful hedge funds in the world and analyze their top stock picks so as to gain insight into their collective buying habits...
Bullish On Trump-led America, Druckenmiller Sells Gold, Bets On Economy
Stanley Druckenmiller is an American hedge fund manager who ran the $12 billion Duquesne Capital till 2010.
Here’s What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why It’s So Important
OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical giant Merck...
Apple Inc. (AAPL), Alphabet Inc (GOOGL), More: See What This $36 Billion Hedge Fund Was Buying in Q3
Adage Capital Management is a Boston-based hedge fund founded in 2001 by Phil Gross and Robert Atchinson.
5 Healthcare Stocks Kahn Brothers Is Bullish On
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
FDA Approves Merck & Co., Inc. (MRK) Keytruda For NSCLC
The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc.
Merck & Co. Inc. (MRK) Shuts Down Florida Facility
The pharmaceutical giant intends to lay off employees in two waves, the first of which is set next month and the other one in December.
Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)
Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process...
Bourgeon Capital Management Reveals Top Picks for Q3, With JPMorgan Chase & Co. (JPM) Leading the Pack
Bourgeon Capital Management LLC, founded by John A.
Trending Stocks: Xerox, LyondellBasell, Enbridge, and 2 More
U.S. stock futures are flat this morning following a decline in crude prices over worries surrounding renewed oversupply.
Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK)
On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc.
Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape
Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually on a hunch.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Pre-Market Primer: Why Investors Will be Watching Tesla, Merck, and Three Other Stocks Today
All three index futures are in the red in this morning's pre-market as traders worry about a potential Brexit.
Five Dividend Stocks Hedge Funds Love
Oil baron and America's first billionaire John D.
Kahn Brothers’ Top Stock Picks: Merck & Co. Inc. (MRK) Overtakes Citigroup Inc. (C) as Top Holding
Kahn Brothers Group is a New York-based hedge fund firm founded by Irving Kahn, Thomas Graham Kahn and Alan Kahn in 1978.
Why Merck, Whole Foods Market & Other Stocks Are in Spotlight Today?
The US Stock market is trading higher on Thursday, helped by a 3% growth in Brent and WTI.
Five Healthcare Stocks Added to HealthInvest Partners’ Portfolio in Q1
HealthInvest Partners is a Stockholm-based fund management company founded by Carl Bennet and Anders Hallberg in 2006.
Here is What Hedge Funds Think About Merck & Co., Inc. (MRK)
At Insider Monkey we follow almost 800 of the best-performing investors and even though many of them lost money in the last several months, the history teaches us that over the...
Kahn Brothers’ Top Stock Picks for Early 2016; Citigroup Inc. (C) Leading the Pack
The Kahn Brothers Group, formerly known as Kahn Brothers & Company Inc., was founded in 1978 by renowned investor Irving Kahn, who died last year at the age of 109.
What Does Hedge Fund Sentiment Say About Merck & Co., Inc. (MRK)?
Does Merck & Co., Inc. (NYSE:MRK) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the company.
Bourgeon Capital Loves These Five Stocks. Should You?
John A. Zaro, a Stanford graduate and a member of the New York Society of Security Analysts, founded Bourgeon Capital in 1999.
Why Are These Five Stocks in Focus on Tuesday?
With the earnings season in progress, investors can take a step back from following macroeconomic news and focus on the financial results reported by individual companies.
Merck & Co., Inc. (MRK), Monster Beverage Corp (MNST) Jump On Analyst Upgrades
Shares of Merck & Co., Inc. (NYSE:MRK) and Monster Beverage Corp (NASDAQ:MNST) have both moved upward today thanks to bullish ratings updates by major analysts.
Madison Street Partners Reshuffles Its Portfolio and Bets on ETFs; See Its Top Stock Picks
Steven Owsley's Madison Street Partners recently filed its 13F form for the second quarter with the SEC.
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Citigroup Inc (C) Top Kahn Brothers’ Portfolio
Kahn Brothers Advisors LLC is an Investment Advisor company providing brokerage and money management services to clients.
Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr.
